• 4931 Citations
  • 38 Scopus h-Index
19992019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Tanios Bekaii-Saab is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 28 Similar Profiles
gemcitabine Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
irinotecan Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

8 Citations (Scopus)

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline

Shroff, R. T., Kennedy, E. B., Bachini, M., Bekaii-Saab, T., Crane, C., Edeline, J., El-Khoueiry, A., Feng, M., Katz, M. H. G., Primrose, J., Soares, H. P., Valle, J. & Maithel, S. K., Apr 20 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 12, p. 1015-1027 13 p.

Research output: Contribution to journalArticle

Biliary Tract Neoplasms
Practice Guidelines
Gallbladder Neoplasms
Cholangiocarcinoma
Randomized Controlled Trials

A Rare EGFR–SEPT14 Fusion in a Patient with Colorectal Adenocarcinoma Responding to Erlotinib

Li, Y., Zhang, H. B., Chen, X., Yang, X., Ye, Y., Bekaii-Saab, T., Zheng, Y. & Zhang, Y., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Epidermal Growth Factor Receptor
Adenocarcinoma
Protein-Tyrosine Kinases
Gene Fusion

Assessment of Treatment with Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients with Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial

Abou-Alfa, G. K., Shi, Q., Knox, J. J., Kaubisch, A., Niedzwiecki, D., Posey, J., Tan, B. R., Kavan, P., Goel, R., Lammers, P. E., Bekaii-Saab, T. S., Tam, V. C., Rajdev, L., Kelley, R. K., El Dika, I., Zemla, T., Potaracke, R. I., Balletti, J., El-Khoueiry, A. B., Harding, J. H. & 7 others, Suga, J. M., Schwartz, L. H., Goldberg, R. M., Bertagnolli, M. M., Meyerhardt, J., O'Reilly, E. M. & Venook, A. P., Jan 1 2019, (Accepted/In press) In : JAMA Oncology.

Research output: Contribution to journalArticle

Doxorubicin
Hepatocellular Carcinoma
Randomized Controlled Trials
Survival
Therapeutics

A Systematic Review and Network Meta-Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer

Sonbol, M. B., Benkhadra, R., Wang, Z., Firwana, B., Walden, D. J., Mody, K., Hubbard, J. M., Murad, M. H., Ahn, D. & Bekaii-Saab, T., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalReview article

Colorectal Neoplasms
Disease-Free Survival
Survival
irinotecan
oxaliplatin